Sage Journals: Discover world-class research

Retricted access

Review article

First published 2012-8

Second-Generation Antipsychotic Use in Schizophrenia and Associated Weight Gain: A Critical Review and Meta-Analysis of Behavioral and Pharmacologic Treatments

Chandan Das, Guillermo Mendez, Sonal Jagasia [...]

Annals of Clinical Psychiatry

Retricted access

Research article

First published 2007-10

Psychopharmacologic Strategies and Associated Challenges in the Long-Term Treatment of Schizophrenia

Geoffry Phillips McEnany

Journal of the American Psychiatric Nurses Association

Open access

Review article

First published 2009

Antipsychotic Drug Treatment for Patients with Schizophrenia: Theoretical Background,Clinical Considerations and Patient Preferences

René Ernst Nielsen, Jimmi Nielsen

Clinical Medicine Insights: Therapeutics

Retricted access

Research article

First published 1997-1

Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia

G.F. Busatto, R.W. Kerwin

Journal of Psychopharmacology

Retricted access

Other

First published 1997-7

What is an atypical antipsychotic?

Gavin P. Reynolds

Journal of Psychopharmacology

Open access

Research article

First published 2022

Effect of long-acting injectable antipsychotics on hospitalizations and global functioning in schizophrenia: a naturalistic mirror-image study

Cristiana Montemagni, Elisa Del Favero, Elena Cocuzza [...]

Therapeutic Advances in Psychopharmacology

Retricted access

Review article

First published 2004-09

Receptor Mechanisms in the treatment of Schizophrenia

Gavin P. Reynolds

Journal of Psychopharmacology

Retricted access

Research article

First published 1999-05

Pharmacological stress diathesis syndromes

David Healy, Richard Tranter

Journal of Psychopharmacology

Retricted access

Research article

First published 2001-07

Antipsychotic induced hyperprolactinaemia: a series of illustrative case reports

Peter M. Haddad, Jonathan S. E. Hellewell, Angelika Wieck

Journal of Psychopharmacology

Open access

Article commentary

First published 2021-9

High dose antipsychotic polypharmacy and dopamine partial agonists - time to rethink guidelines?

Gavin P Reynolds

Journal of Psychopharmacology

Search results